| Synonyms: | Octadecanamide,N-[(1S,2R,3E)-1-[[[O-b-D-galactopyranosyl-(1®3)-O-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)-O-[N-acetyl-1-(1-methylethyl)-a-neuraminosyl-(2®3)]-O-b-D-galactopyranosyl-(1®4)-b-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecenyl]-(9CI); Octadecanamide, N-[1-[[[O-[N-acetyl-1-(1-methylethyl)-a-neuraminosyl]-(2®3)-O-[O-b-D-galactopyranosyl-(1®3)-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)]-O-b-D-galactopyranosyl-(1®4)-b-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecenyl]-,[R-[R*,S*-(E)]]-; AGF 44; Mipragoside; Octadecanamide,N-[(1S,2R,3E)-1-[[[O-[N-acetyl-1-(1-methylethyl)-a-neuraminosyl]-(2®3)-O-[O-b-D-galactopyranosyl-(1®3)-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)]-O-b-D-galactopyranosyl-(1®4)-b-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecenyl]- |
| InChI: | InChI=1/C76H137N3O31/c1-7-9-11-13-15-17-19-21-22-24-26-28-30-32-34-36-55(90)79-47(48(87)35-33-31-29-27-25-23-20-18-16-14-12-10-8-2)43-100-72-64(97)62(95)66(53(41-83)104-72)106-74-65(98)70(110-76(75(99)101-44(3)4)37-49(88)56(77-45(5)85)69(109-76)58(91)50(89)38-80)67(54(42-84)105-74)107-71-57(78-46(6)86)68(60(93)52(40-82)102-71)108-73-63(96)61(94)59(92)51(39-81)103-73/h33,35,44,47-54,56-74,80-84,87-89,91-98H,7-32,34,36-43H2,1-6H3,(H,77,85)(H,78,86)(H,79,90)/b35-33+/t47-,48+,49+,50+,51+,52+,53+,54+,56-,57+,58+,59-,60-,61-,62+,63+,64+,65+,66+,67-,68+,69-,70+,71-,72+,73-,74-,76+/m0/s1 |
